We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Indivior plc (INDV) USD0.1

Sell:232.00p Buy:232.40p 0 Change: 0.60p (0.26%)
FTSE 250:0.96%
Market closed Prices as at close on 18 January 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:232.00p
Buy:232.40p
Change: 0.60p (0.26%)
Market closed Prices as at close on 18 January 2022 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:232.00p
Buy:232.40p
Change: 0.60p (0.26%)
Market closed Prices as at close on 18 January 2022 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Indivior PLC is a United Kingdom-based pharmaceutical company. The Company is engaged in developing medicines to treat addiction and serious mental illnesses. It focuses to build a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and cooccurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as new therapies to address the needs of people suffering from alcohol, stimulant and cannabis use disorders. Its pipeline products include INDV-3000 - Selective Dopamine D3-receptor Antagonist, RBP-6000 - Buprenorphine XR injection, Buprenorphine/ Naloxone Sublingual Film, Buprenorphine/ Naloxone Sublingual Tablet and Buprenorphine Sublingual Tablet, among others. Its portfolio of products is available in more than 40 countries.

Contact details

Address:
234 Bath Road
SLOUGH
SL1 4EE
United Kingdom
Telephone:
+44 (01753) 217800
Website:
indivior.com/

Important dates

Future events
There are no future events available.
Past events
Quarter 3 results 28 October 2021 28/10/21
Interim results 29 July 2021 29/07/21
AGM 06 May 2021 06/05/21
Quarterly results 29 April 2021 29/04/21
Annual report 31 March 2021 31/03/21
Final results 18 February 2021 18/02/21

General stock information

EPIC:
INDV
ISIN:
GB00BRS65X63
Market cap:
£1.63 billion
Shares in issue:
702.18 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 250,FTSE 350,FTSE All Share

Key personnel

  • Mark Crossley
    Chief Executive Officer, Executive Director
  • Ryan Preblick
    Chief Financial Officer, Executive Director
  • Jon Fogle
    Chief Human Resource Officer
  • Christian Heidbreder
    Chief Scientific Officer
  • Cynthia Cetani
    Chief Integrity and Compliance Officer
  • Murali Gopal
    Chief Medical Officer
  • Richard Simkin
    Chief Commercial and Strategy Officer
  • Jon Wasserman
    Interim Chief Legal Officer
  • Hillel West
    Chief Supply Officer
  • Kathryn Hudson
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.